@FiercePharma: Texas Tech scientists discover that antibiotic-resistant bugs from cattle lots are airborne. FierceAnimalHealth story | Follow @FiercePharma
@CarlyHFierce: ICYMI: Actavis execs up for $101M in merger-related bonuses, if investors approve. Story | Follow @CarlyHFierce
> AbbVie's ($ABBV) anti-inflammatory blockbuster Humira won European approval as a treatment for children with severe psoriasis. Report
> Daiichi Sankyo's U.S. subsidiary says it will merge with a U.S.-based sister company, Asubio Pharmaceuticals, and fold the latters R&D projects into its own development operation. Report
> British drugmaker BTG lifted its fiscal year forecast, saying it's looking for 345 million pounds, about $528 million, on the low end. Report
> Opioid misuse in patients with chronic pain is about 25%, according to a new study published in the journal PAIN. Report
Medical Device News
@FierceMedDev: Japanese researchers study carbon nanotubes with drug delivery applications. FierceDrugDelivery story | Follow @FierceMedDev
@StacyALawrence: ICYMI: App enabling iPhone to function as hearing aid launched. Article | Follow @StacyALawrence
@VarunSaxena2: Pilot program deploying COPD Navigator app launched with participation of Mount Sinai hospital. Story | Follow @VarunSaxena2
@EmilyWFierce: Check out this week's edition of FierceLifeSci here, feat. $SHPG, $NVO, $PHG and a #FierceMadness update. Issue | Follow @EmilyWFierce
> Boston Scientific buys endoscopic, ultrasound pancreatic treatment startup for $75M+. Article
> Israeli scientist developing novel wound-closing laser. Item
> Medtronic tries again in renal denervation after previous trial failure. More
Biotech News
@FierceBiotech: Index Ventures banks 650M euros for its new tech fund. Story | Follow @FierceBiotech
@JohnCFierce: Novartis steps in to help bankroll CRISPR-Cas9 pioneer Caribou. Article | Follow @JohnCFierce
@DamianFierce: Serious question: Is the $SRPT hold muzak an instrumental of "I'm all out of love / I'm so lost without you?" | Follow @DamianFierce
> Ipsen barrels into Boston with a new R&D hub and a Harvard pact. Story
> Sanofi adds a $120M computational drug design deal with Schrödinger. Article
> AstraZeneca razes R&D facilities in Delaware. Item
CRO News
> Piramal sells its CRO division to India's Indoco. Item
> WuXi and AstraZeneca roll toward Chinese approval with an arthritis drug. More
> Quintiles and Quest team up for lab testing with $575M JV. Report
> PPD's X-Chem flips some potential drugs to partner Navitor. Story
> Parexel buys an Indian CRO with an eye on drug safety. Article
Vaccines News
> Pfizer pulls vaccines sales business out of China. More
> Analysts: GSK shingles vaccine could steal market share from Merck's Zostavax. Story
> Sanofi, Merck win EMA nod for Gardasil 9. News
> GlaxoSmithKline and Merck Ebola vaccines succeed in Phase II Liberian trials. More
> GSK finally seals U.K. Bexsero deal for £20 per dose. Article
Pharma Manufacturing News
> Drug distributor goes 'Google' style with new facility. Article
> Catalent wraps another Asia-Pacific deal with Pharmapak buy. More
> Biocon's Syngene to build a plant in India. Story
> IPCA Labs' CRO in U.K. adding API space. Item
> Doctor to pay $2M, pleads guilty to dispensing foreign cancer drugs. Article
Pharma Asia News
> Infinity pulls trigger on Takeda oncology candidate option. More
> Takeda looks to settle thousands of Actos U.S. lawsuits for $2B. Article
> HK's Sihuan in partnership with Covance on drug development. Item
> India's Dr Reddy's snaps up some UCB brands in South Asia for $128.3M. Story
> Neurocrine and Mitsubishi Tanabe in license deal on Huntington's disease candidate. Report
And Finally... A small retrospective study found that adding an SGLT-2 diabetes therapy to a GLP-1 drug can result in additional weight loss for patients. Report